12/15-Lipoxygenase metabolites of arachidonic acid activate PPARγ: A possible neuroprotective effect in ischemic brain

Journal of Lipid Research

Volumn 56, Issue 3, 2015, Pages 502-514

  Sun, Li ^a   Xu, Yan Wei ^a   Han, Jing ^a   Liang, Hao ^a   Wang, Ning ^a   Cheng, Yan ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Brain ischemia; Hydroxyeicosatetraenoic acid; Peroxisome proliferator activated receptor

Indexed keywords

ARACHIDONATE 12 LIPOXYGENASE; ARACHIDONATE 15 LIPOXYGENASE; CYCLOOXYGENASE 2; DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NITRIC OXIDE SYNTHASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; 12 HYDROXYICOSATETRAENOIC ACID; 12-15-LIPOXYGENASE; 15-HYDROXY-5,8,11,13-EICOSATETRAENOIC ACID; 2-CHLORO-5-NITROBENZANILIDE; ANILIDE; ARACHIDONIC ACID; HYDROXYICOSATETRAENOIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CELL; BRAIN ISCHEMIA; CONTROLLED STUDY; DNA BINDING; MALE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; REGULATORY MECHANISM; ACTIVE TRANSPORT; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL NUCLEUS; DRUG EFFECTS; ENZYME ACTIVATION; METABOLISM; NERVE CELL; PATHOLOGY; SPRAGUE DAWLEY RAT;

12-HYDROXY-5,8,10,14-EICOSATETRAENOIC ACID; ACTIVE TRANSPORT, CELL NUCLEUS; ANILIDES; ANIMALS; ARACHIDONATE 12-LIPOXYGENASE; ARACHIDONATE 15-LIPOXYGENASE; ARACHIDONIC ACID; BRAIN ISCHEMIA; CELL NUCLEUS; ENZYME ACTIVATION; HYDROXYEICOSATETRAENOIC ACIDS; MALE; NEURONS; PPAR GAMMA; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84925293980     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M053058     Document Type: Article

References (86)

1. Brash, A. R. 1999. Lipoxygenases: occurrence, functions, catalysis, and acquisition of substrate. J. Biol. Chem. 274: 23679-23682.
2. Dobrian, A. D., D. C. Lieb, B. K. Cole, D. A. Taylor-Fishwick, S. K. Chakrabarti, and J. L. Nadler. 2011. Functional and pathological roles of the 12- and 15-lipoxygenases. Prog. Lipid Res. 50: 115-131.
3. Nishiyama, M., H. Okamoto, T. Watanabe, T. Hori, T. Hada, N. Ueda, S. Yamamoto, H. Tsukamoto, K. Watanabe, and T. Kirino . 1992. Localization of arachidonate 12-lipoxygenase in canine brain tissues. J. Neurochem. 58: 1395-1400.
4. Nishiyama, M., T. Watanabe, N. Ueda, H. Tsukamoto, and K. Watanabe. 1993. Arachidonate 12-lipoxygenase is localized in neurons, glial cells, and endothelial cells of the canine brain. J. Histochem. Cytochem. 41: 111-117.
5. Shimizu, T., and L. S. Wolfe. 1990. Arachidonic acid cascade and signal transduction. J. Neurochem. 55: 1-15.
6. Praticò, D., V. Zhukareva, Y. Yao, K. Uryu, C. D. Funk, J. A. Lawson, J. Q. Trojanowski, and V. M. Lee. 2004. 12/15-Lipoxygenase is increased in Alzheimer's disease: possible involvement in brain oxidative stress. Am. J. Pathol. 164: 1655-1662.
7. Watanabe, T., J. F. Medina, J. Z. Haeggström, O. Rådmark, and B. Samuelsson. 1993. Molecular cloning of a 12-lipoxygenase cDNA from rat brain. Eur. J. Biochem. 212: 605-612.
8. Piomelli, D., A. Volterra, N. Dale, S. A. Siegelbaum, E. R. Kandel, J. H. Schwartz, and F. Belardetti. 1987. Lipoxygenase metabolites of arachidonic acid as second messengers for presynaptic inhibition of Aplysia sensory cells. Nature. 328: 38-43.
9. Ruehr, M. L., L. Zhang, and R. V. Dorman. 1997. Lipid-dependent modulation of Ca2+ availability in isolated mossy fiber nerve endings. Neurochem. Res. 22: 1215-1222.
10. Chabot, C., J. Gagne, C. Giguere, J. Bernard, M. Baudry, and G. Massicotte. 1998. Bidirectional modulation of AMPA receptor properties by exogenous phospholipase A2 in the hippocampus. Hippocampus. 8: 299-309.
11. Manzoni, O. J., and J. T. Williams. 1999. Presynaptic regulation of glutamate release in the ventral tegmental area during morphine withdrawal. J. Neurosci. 19: 6629-6636.
12. Freeman, E. J., D. S. Damron, D. M. Terrian, and R. V. Dorman. 1991. 12-Lipoxygenase products attenuate the glutamate release and Ca2+ accumulation evoked by depolarization of hippocampal mossy fiber nerve endings. J. Neurochem. 56: 1079-1082.
13. Yigitkanli, K., A. Pekcec, H. Karatas, S. Pallast, E. Mandeville, N. Joshi, N. Smirnova, I. Gazaryan, R. R. Ratan, J. L. Witztum, et al. 2013. Inhibition of 12/15-lipoxygenase as therapeutic strategy to treat stroke. Ann. Neurol. 73: 129-135.
14. van Leyen, K., H. Y. Kim, S. R. Lee, G. Jin, K. Arai, and E. H. Lo. 2006. Baicalein and 12/15-lipoxygenase in the ischemic brain. Stroke. 37: 3014-3018.
15. Jin, G., K. Arai, Y. Murata, S. Wang, M. F. Stins, E. H. Lo, and K. van Leyen. 2008. Protecting against cerebrovascular injury: contributions of 12/15-lipoxygenase to edema formation after transient focal ischemia. Stroke. 39: 2538-2543.
16. Bazan, N. G., V. L. Marcheselli, and K. Cole-Edwards. 2005. Brain response to injury and neurodegeneration: endogenous neuroprotective signaling. Ann. N. Y. Acad. Sci. 1053: 137-147.
17. Belayev, L., L. Khoutorova, K. D. Atkins, and N. G. Bazan. 2009. Robust docosahexaenoic acid-mediated neuroprotection in a rat model of transient, focal cerebral ischemia. Stroke. 40: 3121-3126.
18. Marcheselli, V. L., S. Hong, W. J. Lukiw, X. H. Tian, K. Gronert, A. Musto, M. Hardy, J. M. Gimenez, N. Chiang, C. N. Serhan, et al. 2003. Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infi ltration and pro-infl ammatory gene expression. J. Biol. Chem. 278: 43807-43817.
19. Lakshmi, S. P., A. T. Reddy, Y. Zhang, F. C. Sciurba, R. K. Mallampalli, S. R. Duncan, and R. C. Reddy. 2014. Down-regulated peroxisome proliferator-activated receptor gamma (PPARgamma) in lung epithelial cells promotes a PPARgamma agonist-reversible proinfl ammatory phenotype in Chronic Obstructive Pulmonary Disease (COPD). J. Biol. Chem. 289: 6383-6393.
20. Ballesteros, I., M. I. Cuartero, J. M. Pradillo, J. de la Parra, A. Pérez-Ruiz, A. Corbí, M. Ricote, J. A. Hamilton, M. Sobrado, J. Vivancos, et al. 2014. Rosiglitazone-induced CD36 up-regulation resolves inflammation by PPARgamma and 5-LO-dependent pathways. J. Leukoc. Biol. 95: 587-598.
21. Ramkalawan, H., Y. Z. Wang, A. Hurbungs, Y. F. Yang, F. F. Tian, W. B. Zhou, J. Li, H. Yang, B. Xiao, and W. Zhang. 2012. Pioglitazone, PPARgamma agonist, attenuates experimental autoimmune neuritis. Inflammation. 35: 1338-1347.
22. Sundararajan, S., J. L. Gamboa, N. A. Victor, E. W. Wanderi, W. D. Lust, and G. E. Landreth. 2005. Peroxisome proliferator-activated receptor-gamma ligands reduce inflammation and infarction size in transient focal ischemia. Neuroscience. 130: 685-696.
23. Zhao, Y., A. Patzer, P. Gohlke, T. Herdegen, and J. Culman. 2005. The intracerebral application of the PPARgamma-ligand pioglitazone confers neuroprotection against focal ischaemia in the rat brain. Eur. J. Neurosci. 22: 278-282.
24. Collino, M., M. Aragno, R. Mastrocola, M. Gallicchio, A. C. Rosa, C. Dianzani, O. Danni, C. Thiemermann, and R. Fantozzi. 2006. Modulation of the oxidative stress and inflammatory response by PPAR-gamma agonists in the hippocampus of rats exposed to cerebral ischemia/reperfusion. Eur. J. Pharmacol. 530: 70-80.
25. Luo, Y., W. Yin, A. P. Signore, F. Zhang, Z. Hong, S. Wang, S. H. Graham, and J. Chen. 2006. Neuroprotection against focal ischemic brain injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone. J. Neurochem. 97: 435-448.
26. Zhao , X. , R. Strong , J. Zhang , G. Sun , J. Z. Tsien , Z. Cui , J. C. Grotta , and J. Aronowski . 2009 . Neuronal PPARgamma defi ciency increases susceptibility to brain damage after cerebral ischemia. J. Neurosci. 29 : 6186-6195.
27. Zhang, H. L., M. Xu, C. Wei, A. P. Qin, C. F. Liu, L. Z. Hong, X. Y. Zhao, J. Liu, and Z. H. Qin. 2011. Neuroprotective effects of pioglitazone in a rat model of permanent focal cerebral ischemia are associated with peroxisome proliferator-activated receptor gammamediated suppression of nuclear factor-kappaB signaling pathway. Neuroscience. 176: 381-395.
28. Li, Q., Y. P. Cheon, A. Kannan, S. Shanker, I. C. Bagchi, and M. K. Bagchi. 2004. A novel pathway involving progesterone receptor, 12/15-lipoxygenase-derived eicosanoids, and peroxisome prolifer-ator-activated receptor gamma regulates implantation in mice. J. Biol. Chem. 279: 11570-11581.
29. Altmann, R., M. Hausmann, T. Spöttl, M. Gruber, A.W. Bull, K. Menzel, D. Vogl, H. Herfarth, J. Schölmerich, W. Falk, and G. Rogler. 2007. 13-Oxo-ODE is an endogenous ligand for PPARgamma in human colonic epithelial cells. Biochem. Pharmacol. 74: 612-622.
30. Berry, A., P. Balard, A. Coste, D. Olagnier, C. Lagane, H. Authier, F. Benoit-Vical, J. C. Lepert, J. P. Séguéla, J. F. Magnaval, et al. 2007. IL-13 induces expression of CD36 in human monocytes through PPARgamma activation. Eur. J. Immunol. 37: 1642-1652.
31. Limor, R., O. Sharon, E. Knoll, A. Many, G. Weisinger, and N. Stern. 2008. Lipoxygenase-derived metabolites are regulators of peroxisome proliferator-activated receptor gamma-2 expression in human vascular smooth muscle cells. Am. J. Hypertens. 21: 219-223.
32. Chabane, N., N. Zayed, M. Benderdour, J. Martel-Pelletier, J. P. Pelletier, N. Duval, and H. Fahmi. 2009. Human articular chondrocytes express 15-lipoxygenase-1 and -2: potential role in osteoarthritis. Arthritis Res. Ther. 11: R44.
33. Wang, Z. J., C. L. Liang, G. M. Li, C. Y. Yu, and M. Yin. 2006. Neuroprotective effects of arachidonic acid against oxidative stress on rat hippocampal slices. Chem. Biol. Interact. 163: 207-217.
34. Sun, L., L. Yang, Y. Fu, J. Han, Y. Xu, H. Liang, and Y. Cheng. 2013. Capacity of HSYA to inhibit nitrotyrosine formation induced by focal ischemic brain injury. Nitric Oxide. 35: 144-151.
35. Churi, S. B., O. S. Abdel-Aleem, K. K. Tumber, H. Scuderi-Porter, and B. K. Taylor. 2008. Intrathecal rosiglitazone acts at peroxisome proliferator-activated receptor-gamma to rapidly inhibit neuropathic pain in rats. J. Pain. 9: 639-649.
36. Ou, Z., X. Zhao, L. A. Labiche, R. Strong, J. C. Grotta, O. Herrmann, and J. Aronowski. 2006. Neuronal expression of peroxisome proliferator-activated receptor-gamma (PPARgamma) and 15d-prostaglandin J2-mediated protection of brain after experimental cerebral ischemia in rat. Brain Res. 1096: 196-203.
37. Lesuisse, C., and L. J. Martin. 2002. Long-term culture of mouse cortical neurons as a model for neuronal development, aging, and death. J. Neurobiol. 51: 9-23.
38. Tugwood, J. D., I. Issemann, R. G. Anderson, K. R. Bundell, W. L. McPheat, and S. Green. 1992. The mouse peroxisome proliferator activated receptor recognizes a response element in the 5' flanking sequence of the rat acyl CoA oxidase gene. EMBO J. 11: 433-439.
39. Dalby, B., S. Cates, A. Harris, E. C. Ohki, M. L. Tilkins, P. J. Price, and V. C. Ciccarone. 2004. Advanced transfection with Lipofectamine 2000 reagent: primary neurons, siRNA, and high-throughput applications. Methods. 33: 95-103.
40. Victor, N. A., E. W. Wanderi, J. Gamboa, X. Zhao, J. Aronowski, K. Deininger, W. D. Lust, G. E. Landreth, and S. Sundararajan. 2006. Altered PPARgamma expression and activation after transient focal ischemia in rats. Eur. J. Neurosci. 24: 1653-1663.
41. Hampson, A. J., and M. Grimaldi. 2002. 12-hydroxyeicosatetrenoate (12-HETE) attenuates AMPA receptor-mediated neurotoxicity: evidence for a G-protein-coupled HETE receptor. J. Neurosci. 22: 257-264.
42. Romera, C., O. Hurtado, J. Mallolas, M. P. Pereira, J. R. Morales, A. Romera, J. Serena, J. Vivancos, F. Nombela, P. Lorenzo, et al. 2007. Ischemic preconditioning reveals that GLT1/EAAT2 glutamate transporter is a novel PPARgamma target gene involved in neuroprotection. J. Cereb. Blood Flow Metab. 27: 1327-1338.
43. Candelario-Jalil, E., A. González-Falcón, M. García-Cabrera, D. Alvarez, S. Al-Dalain, G. Martínez, O. S. León, and J. E. Springer. 2003. Assessment of the relative contribution of COX-1 and COX-2 isoforms to ischemia-induced oxidative damage and neurodegeneration following transient global cerebral ischemia. J. Neurochem. 86: 545-555.
44. Lerouet, D., V. Beray-Berthat, B. Palmier, M. Plotkine, and I. Margaill. 2002. Changes in oxidative stress, iNOS activity and neutrophil infi ltration in severe transient focal cerebral ischemia in rats. Brain Res. 958: 166-175.
45. Xu, Y. W., L. Sun, H. Liang, G. M. Sun, and Y. Cheng. 2010. 12/15-Lipoxygenase inhibitor baicalein suppresses PPAR gamma expression and nuclear translocation induced by cerebral ischemia/reperfusion. Brain Res. 1307: 149-157.
46. Sobrado, M., M. P. Pereira, I. Ballesteros, O. Hurtado, D. Fernandez-Lopez, J. M. Pradillo, J. R. Caso, J. Vivancos, F. Nombela, J. Serena, et al. 2009. Synthesis of lipoxin A4 by 5-lipoxygenase mediates PPARgamma-dependent, neuroprotective effects of rosiglitazone in experimental stroke. J. Neurosci. 29: 3875-3884.
47. Lin, T. N., W. M. Cheung, J. S. Wu, J. J. Chen, H. Lin, J. J. Chen, J. Y. Liou, S. K. Shyue, and K. K. Wu. 2006. 15d-prostaglandin J2 protects brain from ischemia-reperfusion injury. Arterioscler. Thromb. Vasc. Biol. 26: 481-487.
48. Du, H., X. Chen, J. Zhang, and C. Chen. 2011. Inhibition of COX-2 expression by endocannabinoid 2-arachidonoylglycerol is mediated via PPAR-gamma. Br. J. Pharmacol. 163: 1533-1549.
49. Zhao, Y., F. Calon, C. Julien, J. W. Winkler, N. A. Petasis, W. J. Lukiw, and N. G. Bazan. 2011. Docosahexaenoic acid-derived neuroprotectin D1 induces neuronal survival via secretase- and PPARgamma-mediated mechanisms in Alzheimer's disease models. PLoS ONE. 6: e15816.
50. Liao, Z., J. Dong, W. Wu, T. Yang, T. Wang, L. Guo, L. Chen, D. Xu, and F. Wen. 2012. Resolvin D1 attenuates inflammation in lipopolysaccharide-induced acute lung injury through a process involving the PPARγ/NF-κB pathway. Respir. Res. 13: 110.
51. Li, H., X. Z. Ruan, S. H. Powis, R. Fernando, W. Y. Mon, D. C. Wheeler, J. F. Moorhead, and Z. Varghese. 2005. EPA and DHA reduce LPS-induced inflammation responses in HK-2 cells: evidence for a PPAR-gamma-dependent mechanism. Kidney Int. 67: 867-874.
52. Itoh, T., L. Fairall, K. Amin, Y. Inaba, A. Szanto, B. L. Balint, L. Nagy, K. Yamamoto, and J. W. Schwabe. 2008. Structural basis for the activation of PPARgamma by oxidized fatty acids. Nat. Struct. Mol. Biol. 15: 924-931.
53. Brezinski, M. E., and C. N. Serhan. 1990. Selective incorporation of (15S)-hydroxyeicosatetraenoic acid in phosphatidylinositol of human neutrophils: agonist-induced deacylation and transformation of stored hydroxyeicosanoids. Proc. Natl. Acad. Sci. USA. 87: 6248-6252.
54. Spector, A. A., J. A. Gordon, and S. A. Moore. 1988. Hydroxyeicosatetraenoic acids (HETEs). Prog. Lipid Res. 27: 271-323.
55. Umemura, A., H. Mabe, H. Nagai, and F. Sugino. 1992. Action of phospholipases A2 and C on free fatty acid release during complete ischemia in rat neocortex. Effect of phospholipase C inhibitor and N-methyl-D-aspartate antagonist. J. Neurosurg. 76: 648-651.
56. Adibhatla, R. M., J. F. Hatcher, and R. J. Dempsey. 2003. Phospholipase A2, hydroxyl radicals, and lipid peroxidation in transient cerebral ischemia. Antioxid. Redox Signal. 5: 647-654.
57. Carniglia, L., D. Durand, C. Caruso, and M. Lasaga. 2013. Effect of NDP-alpha-MSH on PPAR-gamma and -beta expression and anti-inflammatory cytokine release in rat astrocytes and microglia. PLoS ONE. 8: e57313.
58. Yin, K. J., Y. Fan, M. Hamblin, J. Zhang, T. Zhu, S. Li, J. R. Hawse, M. Subramaniam, C. Z. Song, R. Urrutia, et al. 2013. KLF11 mediates PPARgamma cerebrovascular protection in ischaemic stroke. Brain 136: 1274 - 1287.
59. Pallast, S., K. Arai, A. Pekcec, K. Yigitkanli, Z. Yu, X. Wang, E. H. Lo, and K. van Leyen. 2010. Increased nuclear apoptosis-inducing factor after transient focal ischemia: a 12/15-lipoxygenasedependent organelle damage pathway. J. Cereb. Blood Flow Metab. 30: 1157-1167.
60. Guo, Y., W. Zhang, C. Giroux, Y. Cai, P. Ekambaram, A. K. Dilly, A. Hsu, S. Zhou, K. R. Maddipati, J. Liu, et al. 2011. Identification of the orphan G protein-coupled receptor GPR31 as a receptor for 12-(S)-hydroxyeicosatetraenoic acid. J. Biol. Chem. 286: 33832-33840.
61. Yin, H., Y. Zhou, M. Zhu, S. Hou, Z. Li, H. Zhong, J. Lu, T. Meng, J. Wang, L. Xia, et al. 2013. Role of mitochondria in programmed cell death mediated by arachidonic acid-derived eicosanoids. Mitochondrion. 13: 209-224.
62. Luo, M., N. Flamand, and T. G. Brock. 2006. Metabolism of arachidonic acid to eicosanoids within the nucleus. Biochim. Biophys. Acta. 1761: 618-625.
63. Spector, A. A. 2009. Arachidonic acid cytochrome P450 epoxygenase pathway. J. Lipid Res. 50 (Suppl): S52-S56.
64. Pascual, G., A. L. Fong, S. Ogawa, A. Gamliel, A. C. Li, V. Perissi, D. W. Rose, T. M. Willson, M. G. Rosenfeld, and C. K. Glass. 2005. A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma. Nature. 437: 759-763.
65. Lee, K. S., S. R. Kim, S. J. Park, H. S. Park, K. H. Min, S. M. Jin, M. K. Lee, U. H. Kim, and Y. C. Lee. 2006. Peroxisome proliferator activated receptor-gamma modulates reactive oxygen species generation and activation of nuclear factor-kappaB and hypoxiainducible factor 1alpha in allergic airway disease of mice. J. Allergy Clin. Immunol. 118: 120-127.
66. Sung, B., S. Park, B. P. Yu, and H. Y. Chung. 2006. Amelioration of age-related infl ammation and oxidative stress by PPARgamma activator: suppression of NF-kappaB by 2,4-thiazolidinedione. Exp. Gerontol. 41: 590-599.
67. Kim, E. K., K. B. Kwon, B. S. Koo, M. J. Han, M. Y. Song, E. K. Song, M. K. Han, J. W. Park, D. G. Ryu, and B. H. Park. 2007. Activation of peroxisome proliferator-activated receptor-gamma protects pancreatic beta-cells from cytokine-induced cytotoxicity via NF kappaB pathway. Int. J. Biochem. Cell Biol. 39: 1260-1275.
68. Lin, A. W., C. C. Chang, and C. C. McCormick. 1996. Molecular cloning and expression of an avian macrophage nitric-oxide synthase cDNA and the analysis of the genomic 5 ? -fl anking region. J. Biol. Chem. 271: 11911-11919.
69. Singer, C. A., K. J. Baker, A. McCaffrey, D. P. AuCoin, M. A. Dechert, and W. T. Gerthoffer. 2003. p38 MAPK and NF-kappaB mediate COX-2 expression in human airway myocytes. Am. J. Physiol. Lung Cell. Mol. Physiol. 285: L1087-L1098.
70. Suh, Y., F. Afaq, J. J. Johnson, and H. Mukhtar. 2009. A plant flavonoid fisetin induces apoptosis in colon cancer cells by inhibition of COX2 and Wnt/EGFR/NF-kappaB-signaling pathways. Carcinogenesis. 30: 300-307.
71. Chinetti, G., J. C. Fruchart, and B. Staels. 2000. Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation. Inflamm. Res. 49: 497-505.
72. Rodríguez-Cruz, M., A. R. Tovar, M. del Prado, and N. Torres . 2005. Molecular mechanisms of action and health benefits of polyunsaturated fatty acids. Rev. Invest. Clin. 57: 457-472.
73. Kim, Y. I., S. Hirai, T. Goto, C. Ohyane, H. Takahashi, T. Tsugane, C. Konishi, T. Fujii, S. Inai, Y. Iijima, et al. 2012. Potent PPARalpha activator derived from tomato juice, 13-oxo-9,11-octadecadienoic acid, decreases plasma and hepatic triglyceride in obese diabetic mice. PLoS ONE. 7: e31317.
74. Ouk, T., S. Gautier, M. Pétrault, D. Montaigne, X. Maréchal, I. Masse, J. C. Devedjian, D. Deplanque, M. Bastide, R. Nevière, et al. 2014. Effects of the PPAR-alpha agonist fenofi brate on acute and short-term consequences of brain ischemia. J. Cereb. Blood Flow Metab. 34: 542-551.
75. Deplanque, D., P. Gelé, O. Pétrault, I. Six, C. Furman, M. Bouly, S. Nion, B. Dupuis, D. Leys, J. C. Fruchart, et al. 2003. Peroxisome proliferator-activated receptor-alpha activation as a mechanism of preventive neuroprotection induced by chronic fenofi brate treatment. J. Neurosci. 23: 6264-6271.
76. Li, Y., P. Maher, and D. Schubert. 1997. A role for 12-lipoxygenase in nerve cell death caused by glutathione depletion. Neuron. 19: 453-463.
77. Takata, S., M. Matsubara, P. G. Allen, P. A. Janmey, C. N. Serhan, and H. R. Brady. 1994. Remodeling of neutrophil phospholipids with 15(S)-hydroxyeicosatetraenoic acid inhibits leukotriene B4-induced neutrophil migration across endothelium. J. Clin. Invest. 93: 499-508.
78. Kühn, H., and V. B. O'Donnell. 2006. Inflammation and immune regulation by 12/15-lipoxygenases. Prog. Lipid Res. 45: 334-356.
79. Wittwer, J., and M. Hersberger. 2007. The two faces of the 15-lipoxygenase in atherosclerosis. Prostaglandins Leukot. Essent. Fatty Acids. 77: 67-77.
80. Canals, S., M. J. Casarejos, S. de Bernardo, E. Rodríguez-Martín, and M. A. Mena. 2003. Nitric oxide triggers the toxicity due to glutathione depletion in midbrain cultures through 12-lipoxygenase. J. Biol. Chem. 278: 21542-21549.
81. Kramer, B. C., J. A. Yabut, J. Cheong, R. Jnobaptiste, T. Robakis, C. W. Olanow, and C. Mytilineou. 2004. Toxicity of glutathione depletion in mesencephalic cultures: a role for arachidonic acid and its lipoxygenase metabolites. Eur. J. Neurosci. 19: 280-286.
82. Riccio, M. M., T. Matsumoto, J. J. Adcock, G. J. Douglas, D. Spina, and C. P. Page. 1997. The effect of 15-HPETE on airway responsiveness and pulmonary cell recruitment in rabbits. Br. J. Pharmacol. 122: 249-256.
83. Lai, C. K., G. D. Phillips, J. R. Jenkins, and S. T. Holgate. 1990. The effect of inhaled 15-(s)-hydroxyeicosatetraenoic acid (15-HETE) on airway calibre and non-specific responsiveness in normal and asthmatic human subjects. Eur. Respir. J. 3: 38-45.
84. Chang, W. C., J. Nakao, H. Orimo, and S. Murota. 1982. Effects of reduced glutathione on the 12-lipoxygenase pathways in rat platelets. Biochem. J. 202: 771-776.
85. Ochi, H., I. Morita, and S. Murota. 1992. Roles of glutathione and glutathione peroxidase in the protection against endothelial cell injury induced by 15-hydroperoxyeicosatetraenoic acid. Arch. Biochem. Biophys. 294: 407-411.
86. Pallast, S., K. Arai, X. Wang, E. H. Lo, and K. van Leyen. 2009. 12/15-Lipoxygenase targets neuronal mitochondria under oxidative stress. J. Neurochem. 111: 882-889. Downloaded from www.jlr.org at ELSEVIER BV, on March 14, 2015